Swaminathan Arun

Swaminathan Arun is listed in filings as Chief Executive Officer at Coya Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 26, 2026, including purchase activity. Recent filings connect the profile to Coya Therapeutics, Inc. (COYA). The current snapshot covers public activity from Nov 12, 2024 to Jan 26, 2026. Reported amounts are shown as $36.7K to $1.5M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.